DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 15 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,186,000 | +86.8% | 81,815 | +27.6% | 0.47% | +75.5% |
| Q2 2016 | $635,000 | +51.6% | 64,124 | +45.4% | 0.27% | +52.0% |
| Q1 2016 | $419,000 | -60.9% | 44,110 | -53.9% | 0.18% | -59.3% |
| Q4 2015 | $1,071,000 | -43.2% | 95,647 | -29.0% | 0.44% | -42.8% |
| Q3 2015 | $1,886,000 | -20.5% | 134,716 | -27.7% | 0.76% | +10.8% |
| Q2 2015 | $2,372,000 | +1.3% | 186,453 | +8.6% | 0.69% | -1.6% |
| Q1 2015 | $2,341,000 | +37.7% | 171,638 | +14.9% | 0.70% | +4.5% |
| Q4 2014 | $1,700,000 | +19.7% | 149,340 | +4.6% | 0.67% | +2.9% |
| Q3 2014 | $1,420,000 | +7.8% | 142,724 | +5.1% | 0.65% | +9.8% |
| Q2 2014 | $1,317,000 | -12.9% | 135,740 | -9.5% | 0.59% | -26.1% |
| Q1 2014 | $1,512,000 | – | 150,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 194,340 | $253,000 | 0.02% |
| MIDDLETON & CO INC/MA | 15,848 | $21,000 | 0.01% |
| Acrospire Investment Management LLC | 4,220 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,942 | $26,000 | 0.00% |
| A.R.T. Advisors, LLC | 32,426 | $42,000 | 0.00% |
| FNY Partners Fund LP | 500 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 43,447 | $56,000 | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 13,200 | $17,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 24,378 | $32,000 | 0.00% |
| MORGAN STANLEY | 7,566 | $10,000 | 0.00% |